# BENDAMUSTINE HYDROCHLORIDE
> **ANDA209814** · Abbreviated New Drug Application (Generic) · Sponsor: CELERITY PHARMS · Approved 2019-01-25
## Drug
- **FDA Application Number:** ANDA209814
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** Bendamustine Hydrochloride
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** IV (INFUSION)
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CELERITY PHARMS
- **First approval:** 2019-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209814)
---
*MORVS · CC0 1.0*